Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment

References

• Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci 2001; 938:83 - 95; http://dx.doi.org/10.1111/j.1749-6632.2001.tb03577.x; PMID: 11458529
   PubMed Web of Science ®Google Scholar
• Christopherson KW 2nd, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305:1000 - 3; http://dx.doi.org/10.1126/science.1097071; PMID: 15310902
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425:841 - 6; http://dx.doi.org/10.1038/nature02040; PMID: 14574413
   PubMed Web of Science ®Google Scholar
• Iscove NN, Nawa K. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion. Curr Biol 1997; 7:805 - 8; http://dx.doi.org/10.1016/S0960-9822(06)00341-1; PMID: 9368765
   PubMed Web of Science ®Google Scholar
• Rujkijyanont P, Beyene J, Wei K, Khan F, Dror Y. Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman-Diamond syndrome. Br J Haematol 2007; 137:537 - 44; http://dx.doi.org/10.1111/j.1365-2141.2007.06608.x; PMID: 17539775
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Dutta RK, Basak P, Das P, Das M, Pereira JA, et al. Alteration in marrow stromal microenvironment and apoptosis mechanisms involved in aplastic anemia: an animal model to study the possible disease pathology. Stem Cells Int 2010; 2010:932354; http://dx.doi.org/10.4061/2010/932354; PMID: 21048856
   PubMed Web of Science ®Google Scholar
• Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA, et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011; 469:362 - 7; http://dx.doi.org/10.1038/nature09733; PMID: 21248843
   PubMed Web of Science ®Google Scholar
• Cheng T. Cell cycle inhibitors in normal and tumor stem cells. Oncogene 2004; 23:7256 - 66; http://dx.doi.org/10.1038/sj.onc.1207945; PMID: 15378085
   PubMed Web of Science ®Google Scholar
• Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008; 322:1861 - 5; http://dx.doi.org/10.1126/science.1164390; PMID: 19095944
   PubMed Web of Science ®Google Scholar
• Hu X, Shen H, Tian C, Yu H, Zheng G, XuFeng R, et al. Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model. Blood 2009; 114:3783 - 92; http://dx.doi.org/10.1182/blood-2009-06-227843; PMID: 19652197
   PubMed Web of Science ®Google Scholar
• Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79:551 - 5; http://dx.doi.org/10.1016/0092-8674(94)90540-1; PMID: 7954821
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9:1149 - 63; http://dx.doi.org/10.1101/gad.9.10.1149; PMID: 7758941
   PubMed Web of Science ®Google Scholar
• Boyer MJ, Cheng T. The CDK inhibitors: potential targets for therapeutic stem cell manipulations?. Gene Ther 2008; 15:117 - 25; http://dx.doi.org/10.1038/sj.gt.3303064; PMID: 17989702
   PubMed Web of Science ®Google Scholar
• Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F, et al. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 2011; 9:247 - 61; http://dx.doi.org/10.1016/j.stem.2011.07.003; PMID: 21885020
   PubMed Web of Science ®Google Scholar
• Li J. Quiescence regulators for hematopoietic stem cell. Exp Hematol 2011; 39:511 - 20; http://dx.doi.org/10.1016/j.exphem.2011.01.008; PMID: 21288477
   PubMed Web of Science ®Google Scholar
• Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804 - 8; http://dx.doi.org/10.1126/science.287.5459.1804; PMID: 10710306
   PubMed Web of Science ®Google Scholar
• Yu H, Yuan Y, Shen H, Cheng T. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 2006; 107:1200 - 6; http://dx.doi.org/10.1182/blood-2005-02-0685; PMID: 16234365
   PubMed Web of Science ®Google Scholar
• Cheng T, Shen H, Rodrigues N, Stier S, Scadden DT. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood 2001; 98:3643 - 9; http://dx.doi.org/10.1182/blood.V98.13.3643; PMID: 11739168
   PubMed Web of Science ®Google Scholar
• Sang L, Coller HA, Roberts JM. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008; 321:1095 - 100; http://dx.doi.org/10.1126/science.1155998; PMID: 18719287
   PubMed Web of Science ®Google Scholar
• Tomita K, Hattori M, Nakamura E, Nakanishi S, Minato N, Kageyama R. The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev 1999; 13:1203 - 10; http://dx.doi.org/10.1101/gad.13.9.1203; PMID: 10323870
   PubMed Web of Science ®Google Scholar
• Yu X, Alder JK, Chun JH, Friedman AD, Heimfeld S, Cheng L, et al. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells 2006; 24:876 - 88; http://dx.doi.org/10.1634/stemcells.2005-0598; PMID: 16513761
   PubMed Web of Science ®Google Scholar
• Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481:457 - 62; http://dx.doi.org/10.1038/nature10783; PMID: 22281595
   PubMed Web of Science ®Google Scholar
• Nie Y, Han YC, Zou YR. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 2008; 205:777 - 83; http://dx.doi.org/10.1084/jem.20072513; PMID: 18378795
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25:977 - 88; http://dx.doi.org/10.1016/j.immuni.2006.10.016; PMID: 17174120
   PubMed Web of Science ®Google Scholar
• Kipreos ET, Pagano M. The F-box protein family. Genome Biol 2000; 1:S3002; http://dx.doi.org/10.1186/gb-2000-1-5-reviews3002; PMID: 11178263
   PubMedGoogle Scholar
• Barbash O, Diehl JA. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough. Cell Cycle 2008; 7:2983 - 6; http://dx.doi.org/10.4161/cc.7.19.6775; PMID: 18818515
   PubMed Web of Science ®Google Scholar
• Onoyama I, Nakayama KI. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice. Cell Cycle 2008; 7:3307 - 13; http://dx.doi.org/10.4161/cc.7.21.6931; PMID: 18948752
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev 2008; 22:986 - 91; http://dx.doi.org/10.1101/gad.1621808; PMID: 18367647
   PubMed Web of Science ®Google Scholar
• Stier S, Cheng T, Forkert R, Lutz C, Dombkowski DM, Zhang JL, et al. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 2003; 102:1260 - 6; http://dx.doi.org/10.1182/blood-2002-10-3053; PMID: 12702511
   PubMed Web of Science ®Google Scholar
• Davis RL, Turner DL. Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 2001; 20:8342 - 57; http://dx.doi.org/10.1038/sj.onc.1205094; PMID: 11840327
   PubMed Web of Science ®Google Scholar
• Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature 1995; 377:355 - 8; http://dx.doi.org/10.1038/377355a0; PMID: 7566092
   PubMed Web of Science ®Google Scholar
• Jarriault S, Le Bail O, Hirsinger E, Pourquié O, Logeat F, Strong CF, et al. Delta-1 activation of notch-1 signaling results in HES-1 transactivation. Mol Cell Biol 1998; 18:7423 - 31; PMID: 9819428
   PubMed Web of Science ®Google Scholar
• Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K, et al. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood 2010; 115:2872 - 81; http://dx.doi.org/10.1182/blood-2009-05-222836; PMID: 19861684
   PubMed Web of Science ®Google Scholar
• Kaneta M, Osawa M, Sudo K, Nakauchi H, Farr AG, Takahama Y. A role for pref-1 and HES-1 in thymocyte development. J Immunol 2000; 164:256 - 64; PMID: 10605019
   PubMed Web of Science ®Google Scholar
• Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 2007; 134:1243 - 51; http://dx.doi.org/10.1242/dev.000786; PMID: 17329370
   PubMed Web of Science ®Google Scholar
• van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435:959 - 63; http://dx.doi.org/10.1038/nature03659; PMID: 15959515
   PubMed Web of Science ®Google Scholar
• Zanotti S, Smerdel-Ramoya A, Canalis E. HES1 (hairy and enhancer of split 1) is a determinant of bone mass. J Biol Chem 2011; 286:2648 - 57; http://dx.doi.org/10.1074/jbc.M110.183038; PMID: 21084301
   PubMed Web of Science ®Google Scholar